Gautier Paux

5PUBLICATIONS
34CO-AUTHORS
Solid tumoursMolecular targetsNgā pūtaiao koiora-hauora, haumanu hoki o te Māori (Māori biomedical and clinical sciences)Cancer therapy (excl. chemotherapy and radiation therapy)Health and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 22, 2024
Use of Seamless Study Designs in Oncology Clinical Development- A Survey Conducted by IDSWG Oncology Sub-team.

Yingwen Dong, Gautier Paux, Kristine Broglio

|Jun 18, 2024
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5.

Javier Cortés, Sara A Hurvitz, Joyce O'Shaughnessy

|Oct 30, 2023
Reply to Y. Yoshitomi et al.

Sara M Tolaney, Elisabeth De Kermadec, Patrick Cohen

|Jul 12, 2023
Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation.

Félix Balazard, Aurélie Bertaut, Élise Bordet

|Jun 22, 2023
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.

Sara M Tolaney, Arlene Chan, Katarina Petrakova

Pageof 1

Frequent Collaborators

3 joint publications

Patrick Cohen

2 joint publications

Sara M Tolaney

2 joint publications

Suzette Delaloge

2 joint publications

Hiroji Iwata